What did @drkatewhiteobgyn actually say?
Dr. Kate White, an OB-GYN, showed herself wearing two estradiol patches simultaneously and explained the practice as a diagnostic experiment. Her core claim: leave your old patch on when you apply a new one, get a few days of overlapping estrogen exposure, and see if your symptoms improve. If they do, "you might need to just go up to the next dose." She consistently told viewers to talk to their prescribing practitioner before acting on this. That last part matters, and we'll get back to it.
She also made a secondary pharmacological claim worth examining separately: that the old patch "will have a couple of days of extra estrogen in it" because a week doesn't divide evenly into a twice-weekly schedule. That's a specific assertion about patch pharmacokinetics, not just anecdote.
Does the science back this up?
The general principle is pharmacologically sound, but the details are messier than the video implies. Estradiol patches are designed to deliver a consistent dose over their labeled wear time, typically 3.5 days for twice-weekly formulations. The problem is that delivery rates are not linear throughout that window.
Research on transdermal estradiol pharmacokinetics shows that serum estradiol levels peak within the first 24-48 hours after patch application and then taper (Roumen et al., 2008, Maturitas). By day 3 or 4, a used patch is delivering meaningfully less estradiol than it did on day one. So the claim that a used patch has "a couple of days of extra estrogen" overstates what's actually happening biochemically. There is residual drug, yes, but the delivery rate has declined substantially. The boost you'd get from overlapping is real but not equivalent to simply wearing two full-dose patches.
The broader concept of using symptom response to titrate HRT dose has clinical support. Guidelines from the Menopause Society acknowledge that individualized dose adjustment based on symptom control is appropriate practice (The Menopause Society, 2023, Menopause).
What did they get wrong (or right)?
Credit where it's due: the framework here is legitimate. Using a short-term overlap as informal evidence that you might benefit from a higher dose is a reasonable clinical heuristic, and Dr. White repeatedly directed viewers to their prescribing provider. That's the right call, and it's worth noting she didn't tell anyone to permanently stack patches or self-titrate without oversight.
Where the video stumbles is the pharmacokinetic claim. Saying the old patch has estrogen in it that will deliver "a couple of days" of meaningful additional dose treats a tapering, time-dependent delivery system like a reservoir with a clean shutoff. It doesn't work that way. A day-3 patch is not delivering close to what a fresh patch delivers. The symptom improvement someone notices during this overlap might be real, but attributing it entirely to residual patch delivery is an oversimplification.
There's also a safety gap in the video: no mention of when overlapping patches would be contraindicated. For someone on a high-normal dose already, or with estrogen-sensitive conditions, even a modest transient spike in exposure is not a trivial variable to ignore.
What should you actually know?
Estradiol patch pharmacokinetics are well-characterized but highly individual. Body temperature, application site, skin hydration, and adipose tissue all affect absorption rates (Stanczyk et al., 2013, Menopause). This means the "extra estrogen" from an old patch varies significantly between people, which is exactly why this should be a conversation with a clinician rather than a DIY protocol.
Standard twice-weekly estradiol patches come in doses ranging from 0.025 mg/day to 0.1 mg/day. If symptoms aren't controlled, the evidence-based path is a formal dose adjustment, not a workaround that delivers an unquantified increment. That said, using a few days of overlap as anecdotal signal before having that dose conversation with your provider? That's not dangerous advice for most people. It's just incomplete advice presented with more pharmacological confidence than the mechanism warrants.
- Always apply new patches to a different skin site than the old one, rotating locations to reduce skin irritation and maintain consistent absorption.
- If you notice better symptom control during an overlap period, document it and bring it to your provider. That's useful clinical information.
- Do not self-titrate by permanently wearing two patches without provider guidance. This is where a reasonable experiment becomes an unsupervised dose change.